Vancomycin-resistant enterococci. Mechanism and clinical relevance
- PMID: 9421703
- DOI: 10.1016/s0891-5520(05)70393-7
Vancomycin-resistant enterococci. Mechanism and clinical relevance
Abstract
Vancomycin-resistant enterococci have spread widely throughout the United States. Mechanisms of glycopeptide resistance are understood to a significant extent. These organisms are associated with considerable morbidity. Treatment options are limited, and control of their spread requires considerable effort and results in increased costs.
Similar articles
-
Spread of vancomycin-resistant enterococci: differences between the United States and Europe.Infect Control Hosp Epidemiol. 1998 Aug;19(8):546-51. doi: 10.1086/647871. Infect Control Hosp Epidemiol. 1998. PMID: 9758053
-
[Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].Wien Klin Wochenschr. 1997 May 9;109(9):293-300. Wien Klin Wochenschr. 1997. PMID: 9265387 Review. German. No abstract available.
-
The treatment and control of vancomycin resistant enterococci.J Antimicrob Chemother. 1996 Nov;38(5):753-6. doi: 10.1093/jac/38.5.753. J Antimicrob Chemother. 1996. PMID: 8961044 No abstract available.
-
Vancomycin-resistant enterococci.Clin Infect Dis. 1998 May;26(5):1196-9. doi: 10.1086/520283. Clin Infect Dis. 1998. PMID: 9597252 Review.
-
Guidelines for the prevention and control of vancomycin resistant enterococci (VRE) in long-term care facilities. Sioux Falls Task Force on Antimicrobial Resistance.S D J Med. 1998 Apr;51(4):127-32. S D J Med. 1998. PMID: 9577692 Review. No abstract available.
Cited by
-
Fecal colonization with vancomycin-resistant enterococci in Australia.Emerg Infect Dis. 2000 Sep-Oct;6(5):534-6. doi: 10.3201/eid0605.000514. Emerg Infect Dis. 2000. PMID: 11202974 Free PMC article.
-
Mechanisms of gram-positive vancomycin resistance (Review).Biomed Rep. 2022 Jan;16(1):7. doi: 10.3892/br.2021.1490. Epub 2021 Nov 26. Biomed Rep. 2022. PMID: 34938536 Free PMC article. Review.
-
Activities of a nitrofurazone-containing urinary catheter and a silver hydrogel catheter against multidrug-resistant bacteria characteristic of catheter-associated urinary tract infection.Antimicrob Agents Chemother. 1999 Dec;43(12):2990-5. doi: 10.1128/AAC.43.12.2990. Antimicrob Agents Chemother. 1999. PMID: 10582894 Free PMC article.
-
Multidrug-resistant Pathogens: Mechanisms of Resistance and Epidemiology.Curr Infect Dis Rep. 2000 Oct;2(5):391-398. doi: 10.1007/s11908-000-0065-1. Curr Infect Dis Rep. 2000. PMID: 11095883
-
Comparative in vitro activities of ciprofloxacin, gemifloxacin, grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of gram-positive cocci.Antimicrob Agents Chemother. 2000 Mar;44(3):802-5. doi: 10.1128/AAC.44.3.802-805.2000. Antimicrob Agents Chemother. 2000. PMID: 10681365 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical